These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36826167)

  • 1. Empowering Tennessee Pharmacists to Initiate PrEP Using Collaborative Pharmacy Practice Agreements.
    Cernasev A; Barenie RE; Wofford BR; Golden J; Walker C
    Clin Pract; 2023 Feb; 13(1):280-287. PubMed ID: 36826167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tennessee Pharmacists' Opinions on Barriers and Facilitators to Initiate PrEP: A Qualitative Study.
    Cernasev A; Walker C; Kerr C; Barenie RE; Armstrong D; Golden J
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: Examining concordance between pharmacy technicians and pharmacists.
    Hopkins R; Josma D; Morris J; Klepser DG; Young HN; Crawford ND
    J Am Pharm Assoc (2003); 2021; 61(1):115-120. PubMed ID: 33214059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Pharmacist Interventions at an Outpatient Renal Transplant Clinic Under a Collaborative Pharmacy Practice Agreement.
    Chelewski R; Rodriguez K; Peter M; Zuckerman A
    J Pharm Pract; 2024 Jun; 37(3):593-599. PubMed ID: 36592136
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrating pharmacists into a kidney transplant clinic: Developing and implementing a collaborative pharmacy practice agreement.
    Rodriguez KE; Chelewski RJ; Peter ME; Zuckerman AD; Choi L; DeClercq J; Langone A
    J Am Pharm Assoc (2003); 2022; 62(1):349-356. PubMed ID: 34340924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss!
    Lopez MI; Grant RM; Dong BJ
    J Am Pharm Assoc (2003); 2020; 60(4):e18-e24. PubMed ID: 32165026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California.
    Hunter LA; Packel LJ; Chitle P; Beltran RM; Rafie S; De Martini L; Dong B; Harris O; Holloway IW; Miyashita Ochoa A; McCoy SI
    Open Forum Infect Dis; 2023 Nov; 10(11):ofad549. PubMed ID: 38023549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing a collaborative practice agreement for HIV pre-exposure prophylaxis in the primary care setting.
    Lee LC; Pollak BA; Coffey CP
    J Am Pharm Assoc (2003); 2023; 63(1):383-388. PubMed ID: 36244883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: A survey of patients receiving antiretroviral therapy.
    Lutz S; Heberling M; Goodlet KJ
    J Am Pharm Assoc (2003); 2021; 61(2):e75-e79. PubMed ID: 33069595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization.
    Kumar A; Ray AB; Blanchard C
    Health Res Policy Syst; 2022 Jan; 20(1):1. PubMed ID: 34980147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midwest pharmacists' familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV.
    Broekhuis JM; Scarsi KK; Sayles HR; Klepser DG; Havens JP; Swindells S; Bares SH
    PLoS One; 2018; 13(11):e0207372. PubMed ID: 30427912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes about community pharmacy access to HIV prevention medications in California.
    Koester KA; Saberi P; Fuller SM; Arnold EA; Steward WT
    J Am Pharm Assoc (2003); 2020; 60(6):e179-e183. PubMed ID: 32665097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health.
    Lopez MI; Cocohoba J; Cohen SE; Trainor N; Levy MM; Dong BJ
    J Am Pharm Assoc (2003); 2020; 60(1):138-144. PubMed ID: 31405804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
    Shaeer KM; Sherman EM; Shafiq S; Hardigan P
    J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacists' acceptance of prescribing pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV).
    Booker C; Murphy AL; Isenor JE; Ramsey TD; Smith AJ; Bishop A; Kelly DV; Woodill L; Richard G; John Wilby K
    Can Pharm J (Ott); 2023; 156(3):137-149. PubMed ID: 37201164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacists' nonprescription syringe dispensing perceptions and behaviors: A three-state descriptive analysis.
    Hagemeier NE; Dowling-McClay K; Baladezaei M; Curtis SJ; Spence M
    Drug Alcohol Depend; 2021 Apr; 221():108597. PubMed ID: 33631542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target users' acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV).
    MacDonald CB; Murphy AL; Isenor JE; Ramsey TD; Furlotte K; Smith AJ; Bishop A; Kelly DV; Woodill L; Booker C; Wilby KJ
    Can Pharm J (Ott); 2023; 156(4):194-203. PubMed ID: 37435507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health.
    Okoro O; Hillman L
    J Am Pharm Assoc (2003); 2018; 58(4):412-420.e3. PubMed ID: 29789257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Qualitative Systematic Literature Review of the Role of U.S. Pharmacists in Prescribing Pre-Exposure Prophylaxis (PrEP).
    Cernasev A; Melton TC; Jasmin H; Barenie RE
    Pharmacy (Basel); 2023 Jan; 11(1):. PubMed ID: 36649019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review.
    Zhao A; Dangerfield DT; Nunn A; Patel R; Farley JE; Ugoji CC; Dean LT
    AIDS Behav; 2022 May; 26(5):1377-1392. PubMed ID: 34669062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.